Enfusion, Clearwater

Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion.
Clearwater acquires Enfusion in $1.5B financial software deal
Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.
Clearwater Analytics acquires software maker Enfusion for $1.5 billion to drive global expansion
Clearwater Analytics has agreed to acquire rival Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund industry.
Clearwater Analytics upgraded to Buy at DA Davidson on ‘strategic’ Enfusion deal
DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion
(Reuters) -Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge ...
Clearwater Analytics to buy Enfusion for $11.25 a share
Clearwater Analytics to acquire Enfusion for $1.5 billion in a cash and stock deal, expanding into hedge fund industry with ...
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion Inc For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.With the bid ...
Crowdfund Insider1d
Clearwater Analytics to Acquire Enfusion, Will Expand Investment Management Platform
Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.
Traders Magazine3d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion
BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a ...
Business Wire2d
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of En…
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...
Enfusion downgraded to Hold from Buy at Stifel
Stifel analyst J. Parker Lane downgraded Enfusion (ENFN) to Hold from Buy with a price target of $11.25, down from $13, after the company ...